Ascorbic acid plus gemcitabine (gem) and erlotinib (erl) in patients with metastatic pancreatic cancer (mPanc): Preliminary safety results. Background: To evaluate the toxicity focussing on hepatic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results